Efremova O.S., Yurin O.G.
Vaccination of HIV-infected patients against pneumococcal infection
|
№3 / 2024
|
Efremova O.S., Yurin O.G.
Features of vaccination of HIV-infected patients
|
№1 / 2024
|
Solomay T.V., Semenenko A.V., Nikitina G.Yu., Shuvalov A.N.
Predictive scenarios for the development of the epidemic process of Epstein-Barr virus infection in the absence of specific prevention measures and their implementation
|
№1 / 2023
|
Kanestri V.G., Kuimova U.A., Goliusova M.D.
Comparative analysis of clinical and laboratory outcomes in HIV-infected patients vaccinated and not vaccinated against COVID-19
|
№3 / 2022
|
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Narkevich A.N.
Analysis of factors influencing the readiness for coronavirus vaccination: results of a survey of HIV-infected patients
|
№3 / 2021
|
Koroleva M.A., Gritsay M.I., Koroleva I.S.
The level and structure of mortality in meningococcal infection in the Russian Federation
|
№1 / 2021
|
Matievskaya N.V., Samoilovich E.O., Kuznetsova E.V., Vasilyev A.V., Semeiko G.V., Miklash L.V., Ostrovskaya O.V.
Clinical, epidemiological, and diagnostic characteristics of measles during its outbreak in a vaccined population
|
№2 / 2020
|
Daminov T.A., Tuychiev L.N., Tadjieva N.U., Murtazaeva Z.B., Kurbanov B.D., Kurbanova G.Sh., Magzumov H.B.
Clinical and epidemiological features of meningococcal infection
|
№1 / 2020
|
Bykov I.P., Sergeev A.G., Toporkova M.G., Mishchenko V.A., Zadorozhnaya I.A., Shlykova G.I.
Herd immunity and pathomorphism of tick-borne viral encephalitis under the conditions of a megalopolis
|
№4 / 2019
|
Platonova T.A., Golubkova A.A., Koltunova E.S., Smirnova S.S., Kuznezova O.A.
The importance of monitoring adherence to vaccinations of different population groups in the structure of the information subsystem of epidemiological surveillance of vaccine prevention
|
№3 / 2019
|
Eremeeva Zh.G., Fazylov V.Kh., Manapova E.R., Yakupova F.M.
Analysis of the effectiveness of specific prevention of hepatitis B in a risk group
|
№3 / 2019
|
Briko N.I., Lopukhov P.D.
Interdisciplinary panel discussion of leading experts of the Russian Federation on vaccination against human papillomavirus infection
|
№4 / 2017
|